{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T13:36:35Z","timestamp":1744205795267,"version":"3.30.1"},"reference-count":4,"publisher":"Medknow","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["smedj"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.11622\/smedj.2020132","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T08:05:51Z","timestamp":1601366751000},"page":"497-497","source":"Crossref","is-referenced-by-count":4,"title":["Lysozyme and mucolytics \u2013 the hidden allergen"],"prefix":"10.4103","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1245-6323","authenticated-orcid":false,"given":"L","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KW","family":"Chong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SH","family":"Goh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2581","published-online":{"date-parts":[[2020,9]]},"reference":[{"key":"ref0","unstructured":"1. Health Sciences Authority, Singapore. HSA updates on the phasing-out of lysozyme containing products as therapeutic products. Available at: https:\/\/www.hsa.gov.sg\/docs\/default-source\/announcements-csg\/hsa-updates\/hsaupdates_phasing-out-of-lysozyme-containing-products.pdf. Accessed September 14, 2020."},{"key":"ref1","unstructured":"2. Audicana Berasategui MT, Barasona Villarejo MJ, Corominas S\u00e1nchez M, et al. Potential hypersensitivity due to the food or food additive content of medicinal products in Spain. J Investig Allergol Clin Immunol 2011; 21:496-506."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/j.1346-8138.2000.tb02191.x","article-title":"A case of toxic epidermal necrolysis-type drug eruption induced by oral lysozyme chloride","volume":"27","author":"Kobayashi","year":"2000","unstructured":"3. Kobayashi M, Yamamoto O, Yasuda H, Asahi M. A case of toxic epidermal necrolysis-type drug eruption induced by oral lysozyme chloride. J Dermatol 2000; 27:401-4.","journal-title":"J Dermatol"},{"key":"ref3","unstructured":"4. Health Sciences Authority, Singapore. Caution on the use of lysozyme-containing products in patients with known egg allergy. Available at: https:\/\/www.hsa.gov.sg\/docs\/default-source\/announcements\/adverse-drug-reaction-news-bulletin\/adr_news_may2018_vol20_no1.pdf. Accessed September 14, 2020."}],"container-title":["Singapore Medical Journal"],"original-title":[],"link":[{"URL":"http:\/\/www.smj.org.sg\/article\/lysozyme-and-mucolytics-%E2%80%93-hidden-allergen","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T10:52:37Z","timestamp":1660042357000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.smj.org.sg\/article\/lysozyme-and-mucolytics-%E2%80%93-hidden-allergen"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":4,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9]]},"published-print":{"date-parts":[[2020,9]]}},"URL":"https:\/\/doi.org\/10.11622\/smedj.2020132","relation":{},"ISSN":["0037-5675"],"issn-type":[{"type":"print","value":"0037-5675"}],"subject":[],"published":{"date-parts":[[2020,9]]}}}